Simple Summary The estimated survival time for glioblastoma patients is extremely low; only
about 5% of patients survive five years post diagnosis. The standard of care for glioblastoma …

Purpose The extent of resection (EOR) is an independent prognostic factor for overall
survival (OS) in adult patients with Glioma Grade 4 (GG4). The aim of the neuro-oncology …

Background: Glioblastoma (GBM) is the most common primary brain tumor. The extent of
resection (EOR) has been claimed as one of the most important prognostic factors …

Simple Summary Several advantages of molecular imaging, namely, positron emission
tomography (PET), have been already described in different settings of glioma management …

Reliable cell labeling and tracking techniques are imperative for elucidating the intricate and
ambiguous interactions between mesenchymal stromal cells (MSCs) and tumors. Here, we …

Abstract Independently, both 5-aminolevulinic acid (5-ALA) and intraoperative
neuromonitoring (IONM) have been shown to improve outcomes with high-grade gliomas …

Glioblastoma (GB) is among the most aggressive and difficult-to-treat brain tumors, with a
median survival of only 12–15 months despite maximal treatments, including surgery …

It is commonly reported that maximizing surgical resection of contrast-enhancing regions in
patients with glioblastoma improves overall survival. Efforts to achieve an improved rate of …

Accurate preoperative map** is crucial for maximizing tumor removal while minimizing
damage to critical brain functions during brain tumor surgery. Navigated transcranial …

Gliomas are infiltrative brain tumors that often involve functional tissue. While maximal safe
resection is critical for maximizing survival, this is challenged by the difficult intraoperative …